• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Alnylam Pharmaceuticals, Inc. (ALNY)

    -NasdaqGS
    100.73 Up 1.32(1.33%) Dec 19, 4:00PM EST
    |After Hours : 100.73 Down 0.00 (0.00%) Dec 19, 5:35PM EST
    Add to Portfolio
    Company EventsGet Company Events for:
    Upcoming Events 
    DateEvent
    Feb 11 - Feb 16, 2015 (Est.)Earnings announcement
    Recent Events 
    DateEvent
    19-Dec-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
    18-Dec-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
    6-Nov-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
    5-Nov-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
    26-Sep-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
    8-Aug-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
    7-Aug-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
    2-Jul-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
    9-May-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
    8-May-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
    2-Apr-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
    24-Mar-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Shareholder Director Nom
    6-Mar-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Regulation FD D
    27-Feb-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification t
    26-Feb-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
    20-Feb-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
    13-Feb-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
    13-Jan-14ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Eq